+++ wiley 2/2

[MumboJumbo]

1. A phase 1, randomized, dose-ranging study of GS-5816, a once-daily NS5A inhibitor, in patients with genotype 1–4 hepatitis C virus
E. Lawitz1,*, B. Freilich2, J. Link3, P. German3, H. Mo3, L. Han3, D. M. Brainard3, J. McNally3, T. Marbury4 andM. Rodriguez-Torres5
Journal of Viral Hepatitis
Volume 22, Issue 12, pages 1011–1019, December 2015

DOI:

http://dx.doi.org/10.1111/jvh.12435

2. Enantiomerically Pure Tribenzotriquinacenes through Stereoselective Synthesis
Wilko Greschner1, Beate Neumann1, Dr. Hans-Georg Stammler1, Prof. Dr. Harald Gröger1,2,* andProf. Dr. Dietmar Kuck
Angewandte Chemie International Edition
Volume 54, Issue 46, pages 13764–13768, November 9, 2015

DOI:

http://dx.doi.org/10.1002/anie.201506906

@}->--

[ddtadd]

1. is open access

Код: Выделить всё

http://onlinelibrary.wiley.com/doi/10.1111/jvh.12435/pdf

2